Document is current

Any future updates will be listed below

Intrinsic fluorescence of the clinically approved multikinase inhibitor nintedanib reveals lysosomal sequestration as resistance mechanism in FGFR-driven lung cancer

Crossref DOI link: https://doi.org/10.1186/s13046-017-0592-3

Published Online: 2017-09-07

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark